ArticleEMBO reports2024

The phosphatase inhibitor LB-100 creates neoantigens in colon cancer cells through perturbation of mRNA splicing.

Matheus H Dias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.